Online Education | Women's Health Drug Therapy 2016 - Osteoporosis: Where Are We Now?
This module examines the various pharmaceutical options available for treating patients with osteoporosis and discusses recommendations for using a drug holiday to modulate the risks and benefits of bisphosphonate therapy.
Christy Weiland-Hamilton, PharmD, BCPS
Clinical Pharmacist, UW Medicine/University of Washington Medical Center, Seattle
Comments from lecture attendees:
"Dr. Christy Weiland's presentation was very informative about the new drugs in osteoporosis."
"Dr. Weiland gave a great review. I appreciated that she emphasized the importance of prevention of osteoporosis."
For women’s health nurse practitioners, family nurse practitioners, clinical nurse specialists, pharmacists and other interested healthcare professionals.
Objectives for Learning Outcomes
After taking this module, you will be better able to:
- Compare and contrast available drug therapy for treating patients with osteoporosis.
- Access appropriateness of a drug holiday for patients taking a bisphosphonate.
- Recognize new developing therapies for osteoporosis.
- 1.00 Contact hours
- 1.00 Pharmacology hours at the advanced practice level